PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-Nov-2021 HAEMATO AG reports figures for the 3rd quarter of 2021: Further increase in revenue and earnings as well as confirmation of revenue and earnings expectations for 2021 HAEMATO AG
17-Nov-2021 New Data Suggests More Doctors Spending Time Addressing COVID-19 Vaccine Misinformation As Compared To Six Months Ago B3C newswire
17-Nov-2021 ProBioGen's GlymaxX® Technology Made It Again into Clinical Phase I B3C newswire
17-Nov-2021 Watson-Marlow Fluid Technology Group Crowned Most Innovative Pharma Fluid Management Solutions Provider 2021 Sciad Newswire
17-Nov-2021 AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Active Psoriatic Arthritis AbbVie
17-Nov-2021 BD Launches BD UltraSafe Plus™ 2.25 mL Passive Needle Guard Enabling Patient Ease of Use and Safety B3C newswire
17-Nov-2021 Cosmo announces regulatory approval of GI Genius™ in Canada Cosmo Pharmaceuticals N.V.
17-Nov-2021 AEVIS VICTORIA SA: Operating revenues at 30 September 2021 up sharply to CHF 620.0 million (2020: CHF 509.9 million; 2019: CHF 513.9 million) AEVIS VICTORIA SA
16-Nov-2021 Takeda calls for collaboration to improve patient access to combination treatments Takeda
16-Nov-2021 Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Extraordinary General Meeting Cosmo Pharmaceuticals N.V.
16-Nov-2021 SOTIO Expands its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration and License Agreement with LegoChem Biosciences B3C newswire
16-Nov-2021 Sernova to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum Sernova Corp.
16-Nov-2021 PharmaSGP reporting 34% revenue growth and increased profitability in Q3 2021 PharmaSGP Holding SE
16-Nov-2021 Dermapharm Holding SE: strong EBITDA growth in Q3 2021 Dermapharm Holding SE
16-Nov-2021 COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH PROVISIONAL INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. Cassiopea S.p.A.
16-Nov-2021 COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH PROVISIONAL INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. Cosmo Pharmaceuticals N.V.
16-Nov-2021 Biotest AG: Cytotect CP(R) Biotest activates immune cells that are crucial to control Cytomegalovirus Biotest AG
15-Nov-2021 Original-Research: MagForce AG (von GBC AG) MagForce AG
15-Nov-2021 Biophytis announces US centers to restart recruitment for the COVA phase 2-3 study with Sarconeos (BIO101) in COVID-19 Biophytis
12-Nov-2021 HumanOptics AG: Merger Squeeze-out registered HumanOptics AG